“Acute gout”的搜索结果，显示 61-70 项，共有 9836 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

2. 急性肝衰竭- 诊断与治疗- 妙佑医疗国际

   ... acute-liver-failure. Accessed July 2, 2024. Stravitz RT, et al. Acute liver failure. The Lancet. 2019; doi:10.1016/S0140-6736(19)31894-X. Goldberg E, et al ...

3. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

4. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

5. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

6. 外科 - 临床试验- 妙佑医疗国际

   ... acute kidney injury in high-risk valve surgery patients. A Study To Analyze Waste Specimens From The Eye After Surgery. Rochester, Minn. The purpose of this ...

7. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic ...

8. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, and explore ...

9. 神经科- 临床试验- 妙佑医疗国际

   VERIFY will validate biomarkers of upper extremity (UE) motor outcome in the acute ischemic stroke window for immediate use in clinical trials, ...

10. 急性髓系白血病- 症状与病因- 妙佑医疗国际

    AskMayoExpert. Acute myeloid leukemia (adult). Mayo Clinic; 2024. Hoffman R, et al. Clinical manifestations and treatment of acute myeloid leukemia. In ...